DOCSLIB.ORG

February 12, 2020 the Honorable Michael Crapo Chairman, United

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
February 12, 2020 the Honorable Michael Crapo Chairman, United February 12, 2020 The Honorable Michael Crapo Chairman, United States Senate Committee on Banking, Housing and Urban Affairs United States Senate Washington, D.C. 20510 Dear Senator Crapo, Thank you for seeking comment on the Secure And Fair Enforcement (SAFE) Banking Act. As you know, the Act passed in the House of Representatives by a bipartisan vote of 321-103. We write to urge you to move the House version through Committee. We are entrepreneurs who work in the cannabis industry or work in industries that support the canna- bis industry. And we are writing because of the crucial importance of the passage of a bill that works for the small businesses that are helping this industry flourish in 33 states. We know from our person- al experiences, and those of our customers, suppliers, and employees, that the SAFE Banking Act as passed by the House of Representatives is the right approach to secure banking and payment pro- cessing services. This is not a partisan issue, or a regional issue. We are a bipartisan group, with operations spread across the United States. The ranks of impacted entrepreneurs is only growing. The state-legal canna- bis industry employs more than 200,000 people (with annual growth of 34%) and is estimated to have generated roughly $12 billion in retail sales in 2019. Longer-term projections see annual retail sales in the United States surpassing $28 billion by 2023. The cannabis industry delivered an estimated $40 billion economic impact on the United States in 2019. By 2023, it is estimated that the economic impact could exceed $100 billion. The industry is projected to add roughly 235,000 new jobs by 2023. By 2023, the cannabis industry could provide the equivalent of 475,000 full time jobs. There is no other American industry seeing this type of growth. Simply put, this is an issue of fairness and of safety. Because of the absence of banking reform that keeps pace with the federal hemp reforms and state-level medical and adult-use reforms, many can- nabis businesses struggle to obtain and maintain bank accounts. Yet, banking is a crucial element for this burgeoning industry to operate safely. Without banking services, U.S. businesses will continue to operate in a cash environment that endangers employees and the public. Every day that we wait is an- other day that our employees and the members of the public who patronize our businesses are at risk of robbery and assault because we operate in an all cash environment. In short, the SAFE Banking Act is a referendum on public safety for our small businesses. We are merely asking that you facilitate the availability of financial services to the hemp and state-legal cannabis industry in order to improve public safety, allow states and the federal government to easily track and collect tax revenue, and assist the state-legal industry to displace an illicit market that is cur- rently operating free from any regulatory oversight. The cannabis industry stands ready to work with your office on the myriad technical issues that you have suggested should be a priority, including making certain that these products are not available to children. Rest assured, these are priorities for us as well and an essential reason that we believe it is long overdue to tackle the illicit market for cannabis products. We urge you to work with the state-regulated cannabis industry, the financial services sector, and other interested stakeholders on a solution that supports, rather than hinders, this burgeoning industry and the will of the American public. Sincerely, Aaron Smith Neal Levine Executive Director Chief Executive Officer National Cannabis Industry Association Cannabis Trade Federation Steve Fox Christian Sederberg President Attorney VS Strategies Vicente Sederberg LLP Alena Rodriguez Steven Hawkins Managing Director Executive Director Rm3 Labs Marijuana Policy Project Michael Cooper John Lord Managing Member CEO and Owner MadisonJay Solutions Livwell Enlightened Health Yoko Miyashita Ryan Arthurs General Counsel Owner Leafly Ianthus Capital Management Omar Figueroa David Dinenberg Lawyer CEO Law Offices of Omar Figueroa Kind Khurshid Khoja Douglas Fischer Principal General Counsel Greenbridge Corporate Counsel Greenlane Andrew Kingsdale Diane Czarkowski Attorney Founding Partner Law Offices of Omar Figueroa Canna Advisors Ramon Alarcon Jeff Conner CEO CFO Wellness Insight Technologies Inc The Kanvas Co Ricardo Baca Lisa Conine Founder & CEO Community Outreach Coordinator Grasslands: A Journalism-Minded Agency Om of Medicine Haskell Kennedy Seun Adedeji President CEO Medicine Man Solutions, LLC Elev8Cannabis AC Braddock David Grigsby CEO Marketing Director Eden Labs Dixie Brands Tim Fitzpatrick Aaron Justis President - Oregon President Curaleaf Oregon, LLC Buds & Roses Collective, Inc Karen Bernstein Etienne Fontan Managing Partner Vice President Bernstein IP Berkeley Patients Group Glen Leibowitz Kris Krane CFO President Acreage Holdings 4Front Ventures Greg Huffaker Jeremy Riggle Director of Client Services Chief Scientist Canna Advisors Mary’s Nutritionals Ryan O’Malley Michael Kraft General Manager Compliance Manager Tahoe Wellness Center Papa & Barkley Patrick Bissen Ryan Zahler CEO Compliance Specialist Planet of The Vapes Flowhub Michael Scanlon Tamara Anderson Owner CEO 20/20 Growth Conferences Culinary and Cannabis Haley Andrew Annie Aubrey CEO CEO Dixon Wellness Chuck’s Wellness Center Elyse Auguste Brandon Bach CEO CEO Matrix Pot Haven Ridge LLC Brian Barbuto Russell Barnett CEO CEO Wrazel Chronic Tax Firm Heidi Baxley David Benett CEO CEO Solid Accounting Solutions LLC Bento Delivery Susan Agostinelli John Blosser CEO CEO Pure Hermosa NovaLux Healthcare Holdings, Inc. Byron Bogard Dana Borys CEO CEO Bynate Dana R. Borys, An Accountancy Corporation Thomas Boudrie David Brown CEO CEO Allitom LLC Elite Extraction Services Jarett Burke Christopher Callaway CEO CEO Kifcure, LLC Eureka Sky Johnna Calvillo Venus Caruso CEO CEO Can of Bliss deep CBDs Garth Case Jake Catt CEO CEO Jamrock Organics Gardenhouse Brands Keysha Charles Douglas Chloupek CEO CEO Kief Organics LLC Juva Life Travis Chrisman Christine Cintron CEO CEO Coastal Labs CDI Enterprise, LLC Karin Clarke Paul Coble CEO CEO KC Business Solutions Thalo Technologies Tara Coomans Robert Crossley CEO CEO Primo PR B&R Labs LLC Glenn Cybulski Steve Decker CEO CEO Tossed Sauced Baked LLC Santa Barbara Cannabis LLC John Delaplane Eric Delisle CEO CEO Equinox Botanicals Bloomstack Corp Brian Dell Daniel Delson CEO CEO Old Goat Farms Daniel Delson Strategic Communication Sevan Derohanian John Devore CEO CEO Shining Sun Distribution Inc. Urbn Farmers Bobby Diaz Mike Dorrance CEO CEO CanSact Evolution Risk LLC Michael Duga Colin Earl CEO CEO BH Partners SISU Consulting Michael Evans Matt Fagan CEO CEO WCW Enterprises LLC Buffalo Investments Aaron Fair Ali Fakhri CEO CEO TotaLeaf, Inc EventHi Inc. Ronald Falcioni Julian Farhoud CEO CEO Out Cannabis E&J Distributors, LLC Naycora Fauntleroy Dennis Ferrigno CEO CEO Codie Inc. The Grown Depot Michele Finn Justin Fischer CEO CEO Jubilee of Wellness VeriLeaf Dion Foley Paul Frank CEO CEO Cali Bio Hemp Solutions of Minnesota, LLC Courtney Freeman Mindy Galloway CEO CEO White Buffalo Khemia Liz Gehl Ron Gershoni CEO CEO Gehl Search Partners Jetty Extracts Melissa Gibson Merril Gilbert CEO CEO Hemp & Humanity TraceTrust Noni Goldman Wendi Goldsmith CEO CEO Four Trees Holyoke LLC Sustainability Visions LLC Kale Gray Nicole Griffith Barbieri CEO CEO Tokyo Starfish Convergence Laboratories, Inc Hab Haddad Noah Hamman CEO CEO GreenPoint AdvisorShares Ed Harris Shannon Hattan CEO CEO Pacific Growth Capital Fiddler’s Greens Martin Higgins Marco Hoffman CEO CEO URBANA Evergreen Herbal John Hopkins Ana Hory CEO CEO Bhang Technologies Inc. Chil LLC David Hua Haley Hunt CEO CEO Meadow Trulevia Douglas Hutchens Vernon Jackson CEO CEO Cannaste We Moving LLC George Jage Mary Jane CEO CEO Jage Media Inc. Miss Mary Jane’s California Jamie Jordan Anne Joyce CEO CEO Humble Oz, LLC. Libertyclothing Reena Kaven Adam Kern CEO CEO Tribe Tetra Worx Inc Krystal Kitahara Krystal Kitahara CEO CEO Yummi Karma Yummi Karma Corey Kite Sharon Krinsky CEO CEO Bonny Doon Organics Society Jane Jeff Kriozere Sara Krishnamachari CEO CEO GreenRX-ID Purple Lotus Patient Center Frank Labrozzi Nate Landau CEO CEO Novus Cannabis Medplan Mother No-Till LLC Diana Starr Langley Ana Leano-Williams CEO CEO Green Rush Alliances, LLC Seaweed Holistics, LLC Joe Leonard Larry Levy CEO CEO Bee Valley Farms Lucid Green Inc. Carsten Loe Tim Lozott CEO CEO YiLoCA Management Group, LLC Green Life Capital Bill Ludlow Karen Lustman CEO CEO CRATIV Packaging Senior-High Barron Lutz Mary Makoul CEO CEO Humboldt Private Reserve Pendram Bob Martin Sergio Mart√≠nez CEO CEO CWAnalytical Kaneh Bioinnovations Mike Mattioli Dennis Mattos CEO CEO DSM Group, LLC Sunbare Tour & Travel Dave McGee Donald McLaughlin CEO CEO Truhapa Capital Purepower Wellness LLC Patrick McManamon Sumit Mehta CEO CEO Cannasure Insurance Services, LLC MAZAKALI Ron Mellon David Mersky CEO CEO ProTerp Holdings, LP Sivannac Inc. Margot Micallef Sheryl Mizicko CEO CEO Sonoma Pacific Distribution Ideal Harvest Kelly Moore Khalil Moutawakkil CEO CEO Jet One Solutions, LLC KindPeoples Paul Muchowski Kelly Murtha CEO CEO Dr. Paul’s Rebel Edibles Ernie Pascua Joseph Pearson CEO CEO HQP Inc SPARC Karen Petersen Gina Pippin CEO CEO Ocanna - Ocannalife The Galley Zachary Pitts Moshe Prystowsky CEO CEO Ganja Goddess Pinsky Associates LLC Kary Radestock Michael Ramirez CEO
Load more

Recommended publications
  • The Advisability and Feasibility of Developing USP Standards for Medical Cannabis Gabriel I
    STIMULI TO THE REVISION PROCESS Stimuli articles do not necessarily reflect the policies of the USPC or the USP Council of Experts The Advisability and Feasibility of Developing USP Standards for Medical Cannabis Gabriel I. Giancaspro, Nam-Cheol Kim, Jaap Venema, Susan de Mars, Jennifer Devine, Carlos Celestino, Christine E. Feaster, Ben A. Firschein, Mary S. Waddell, Stephen M. Gardner, and Earl Jones Jr.a ABSTRACT This Stimuli article analyzes the need for public quality standards for medical cannabis (defined herein as marijuana used for medical purposes under state laws) and the potential role of the U.S. Pharmacopeial Convention (USP) in addressing that need.1 Following legalization of the medical use of cannabis in several U.S. states and internationally, USP has received requests to investigate the advisability and feasibility of developing quality standards for medical cannabis. Development of quality standards for medical cannabis requires consideration of a wide range of scientific, legal, and policy issues that reach far beyond its classification as a botanical drug or herbal medicine. This article discusses the current regulatory and scientific landscape regarding medical cannabis, identifies issues related to the lack of quality standards for medical cannabis, and explores potential options for developing quality standards. USP seeks input from stakeholders on whether USP should proceed with development of quality standards for medical cannabis and if so, what approaches should be utilized to establish such standards. LEGAL AND REGULATORY LANDSCAPE The federal and state regulatory environment surrounding the medical use of cannabis involves many federal agencies and various different state laws. The evolving legal environment is an important consideration when evaluating the advisability and feasibility of USP developing a public standard for cannabis.
    [Show full text]
  • The Official High Times Cannabis Cookbook: More Than 50 Irresistible Recipes That Will Get You High
    CONTENTS ACKNOWLEDGMENTS INTRODUCTION TO CANNABIS COOKERY CHAPTER 1: Active Ingredients Basic Recipes THC Oil (Cannabis-Infused Oil) Cannacoconut Oil Cannabis-Infused Mayonnaise Simple Cannabutter Long-Simmering Cannabutter Wamm Marijuana Flour Tinctures Quick Cannabis Glycerite Long-Simmering Ganja Glycerin Green Avenger Cannabis Tincture CHAPTER 2: Irie Appetizers Roasted Ganja Garlic Cannellini Dip Hookah Lounge Hummus Green Leafy Kale Salad in Brown Cannabutter Vinaigrette Obama’S Sativa Samosas Stuffed Stoned JalapeñO Poppers Sativa Shrimp Spring Rolls with Mango Sauce Ganja Guacamole Mini Kind Veggie Burritos Pico de Ganja and Nachos Kind Bud Bruschetta with Pot Pesto Stoner Celebrity Favorite: Lil’ Snoop Hot Doggy Doggs CHAPTER 3: Munchie Meals Reggae Rice and Bean Soup Cream of Sinsemilla Soup Tom Yum Ganja Stoner Celebrity Favorite: Texas Cannabis Chili Shroomin’ Broccoli Casserole Om Circle Stuffed Butternut Squash Chicken and Andouille Ganja Gumbo Time-Warp Tamales Red, Green, and Gold Rasta Pasta Potato Gnocchi with Wild Mushroom Ragu Big Easy Eggplant Alfredo Ganja Granny’s Smoked Mac ‘n’ Cheese Psychedelic Spanakopita Sour Diesel Pot Pie Cheeto Fried Chicken Bacon-Wrapped Pork Tenderloin with Mango Chipotle Glaze Pot-and-Pancetta-Stuffed Beef Tenderloin with Port Mushrooms CHAPTER 4: High Holidays Valentine’s Day, February 14: Sexy Ganja–Dipped Strawberries St. Patrick’s Day, March 17: Green Ganja Garlic Smashed Potatoes 4/20, Cannabis Day, April 20: 420 Farmers’ Market Risotto Independence Day, July 4: Sweet and Tangy Bar–B–Cannabis
    [Show full text]
  • A Baseline Review and Assessment of the Massachusetts Adult-Use Cannabis Industry: Market Data and Industry Participation
    A Baseline Review and Assessment of the Massachusetts Adult-Use Cannabis Industry: Market Data and Industry Participation February 2020 Massachusetts Cannabis Control Commission: Steven J. Hoffman, Chairman Kay Doyle, Commissioner Jennifer Flanagan, Commissioner Britte McBride, Commissioner Shaleen Title, Commissioner Shawn Collins, Executive Director Prepared by the Massachusetts Cannabis Control Commission Research and Information Technology Departments: Samantha M. Doonan, BA, Research Analyst David McKenna, PhD, Chief Technology Officer Julie K. Johnson, PhD, Director of Research Acknowledgements External Collaborators Alexandra F. Kritikos, MA, Brandeis University Cannabis Control Commission Communications Cedric Sinclair, Director of Communications Maryalice Gill, Press Secretary Kirsten Swenson, Communications Specialist Management Alisa Stack, Chief Operating Officer Erika Scibelli, Chief of Staff Legal Christine Baily, General Counsel Allie DeAngelis, Associate General Counsel Enforcement and Licensing Yaw Gyebi, Chief of Enforcement Paul Payer, Enforcement Counsel Kyle Potvin, Director of Licensing Patrick Beyea, Director of Investigations Derek Chamberlin, Licensing Analyst Anne DiMare, Licensing Specialist Government Affairs David Lakeman, Director of Government Affairs 2 Suggested bibliographic reference format: Doonan SM., McKenna, D., Johnson JK., (2020, February). A Baseline Review and Assessment of the Massachusetts Adult-Use Cannabis Industry— A Report to the Massachusetts Legislature. Boston, MA: Massachusetts Cannabis
    [Show full text]
  • Medical Marijuana the War on Drugs and the Drug Policy Reform Movement
    UNIVERSITY OF CALIFORNIA SANTA CRUZ FROM THE FRONTLINES TO THE BOTTOM LINE: MEDICAL MARIJUANA THE WAR ON DRUGS AND THE DRUG POLICY REFORM MOVEMENT A dissertation submitted in partial satisfaction Of the requirements for the degree of DOCTOR OF PHILOSOPHY in SOCIOLOGY by Thomas R. Heddleston June 2012 The Dissertation of Thomas R. Heddleston is approved: ____________________________________ Professor Craig Reinarman, Chair ____________________________________ Professor Andrew Szasz ____________________________________ Professor Barbara Epstein ___________________________________ Tyrus Miller Vice Provost and Dean of Graduate Studies Copyright © by Thomas R. Heddleston 2012 TABLE OF CONTENTS Introduction 1 Chapter I: The History, Discourse, and Practice of Punitive Drug Prohibition 38 Chapter II: Three Branches Of Reform, The Drug Policy Reform Movement From 1964 To 2012 91 Chapter III: Sites of Social Movement Activity 149 Chapter IV: The Birth of Medical Marijuana In California 208 Chapter V: A Tale of 3 Cities Medical Marijuana 1997-2011 245 Chapter VI: From Movement to Industry 303 Conclusion 330 List of Supplementary Materials 339 References 340 iii LIST OF TABLES AND FIGURES Table 2.1: Major Organizations in the Drug Policy Reform Movement by Funding Source and Organizational Form 144 Table 3.1: Characteristics of Hemp Rallies Attended 158 Table 3.2: Drug Policy Organizations and the Internet 197 Figure 4.1: Proposition 215 Vote November 1996 241 Table 5.1: Political Opportunity Structures and Activist Tools 251 Table 5.2: Key Aspects of Political Opportunity Structures at 3 Levels of Government 263 Figure 5.1: Medical Cannabis Dispensaries by Region and State 283 iv ABSTRACT Thomas R. Heddleston From The Frontlines to the Bottom Line: Medical Marijuana the War On Drugs and the Drug Policy Reform Movement The medical marijuana movement began in the San Francisco Bay Area in the early 1990s in a climate of official repression.
    [Show full text]
  • Amicus Brief
    SUPREME COURT OF ARIZONA STATE OF ARIZONA, Arizona Supreme Court No. CR-18-0370-PR Appellee, Court of Appeals v. Division One No. 1 CA-CR 16-0703 RODNEY CHRISTOPHER JONES, Yavapai County Appellant. Superior Court No. P1300CR201400328 AMICUS CURIAE BRIEF OF ARIZONA DISPENSARIES ASSOCIATION IN SUPPORT OF APPELLANT (Filed with consent of all parties) Eric M. Fraser (027241) OSBORN MALEDON, P.A. 2929 North Central Avenue, Ste. 2100 Phoenix, Arizona 85012 602-640-9000 [email protected] Attorneys for Amicus Curiae Arizona Dispensaries Association TABLE OF CONTENTS Page TABLE OF AUTHORITIES .................................................................................... 3 INTRODUCTION ................................................................................................... 5 INTEREST OF AMICUS CURIAE ........................................................................ 5 REASONS TO GRANT REVIEW .......................................................................... 6 I. The Opinion warrants review because it will have an enormous impact across Arizona. .............................................................. 6 II. The Opinion upends the industry’s settled expectations. ...................... 7 III. Dispensaries manufacture concentrates using well-known, long-established processes that yield products that satisfy a wide range of patient requirements and preferences. ..........................11 A. Concentrates can be made using extremely simple processes. ...........................................................................................11
    [Show full text]
  • Kief USA, LLC D/B/A Hui
    Kief USA, LLC d/b/a Hui, LLC Community Outreach Meeting Proposal for Marijuana Establishment at Presentation July 7, 2021 1 Turner Street, Attleboro, MA (fka 330 Turner Street, Attleboro, MA) LEADERSHIP Hui Zhang, President, Owner Tucker Cole, Master Grower - Women, Minority Entrepreneur - Over ten years of growing experience in the - First Generation Immigrant Entrepreneur horticulture industry - B.S. in Information Technology from - Over five years of experience in the Cannabis University of Wuhan and Master’s in Industry Financial Accounting from Renmin University - Experience in consulting, facility design, account of China management, research, and breeding of Cannabis Project Team - Managed ten thousand square feet greenhouses - Ali Lee, COO - Legal Advisors: Adam Braillard, Ashley Tan, and Ashfin Islam of Prince Lobel Tye LLP - CSI Engineering LLC, James R. O”Brien, LEED, AP BD+C - Keenan + Kenny Architects LTD, Antonia Kenny CANNABIS IN MASSACHUSETTS Massachusetts Industry Snapshot: ● 8,464 Applications, 794 Licenses ● Total gross sales: $1.47B ● 13,005 Agent Registrations PROPOSED FACILITY ● Marijuana Cultivation and Marijuana Product Manufacturing Establishment ● 1 Turner Street, Attleboro, MA (fka 330 Turner Street) ● Approximately ~84,000 SF on second floor ● Hours: 24/7 hours of cultivation ● 15-20 employees; commitment to use best efforts to hire locally and hire diversity ● At least 21 exclusive Parking Spaces for Hui LLC immediately next to the entrance of the Facility ● Product pickup from secure side loading dock ZONING/LOCATION 1 Turner Street, Attleboro, MA (fka 330 Turner Street) • Industrial Zoning District • Second floor of Existing ~84,000 SF building • 21 exclusive Parking Spaces for the proposed Facility (more available on site) • Building is not within 500 feet of any school (grades K-12), day care, public park, etc.
    [Show full text]
  • Ethical Cannabis Lawyering in California Francis J
    University of the Pacific Scholarly Commons McGeorge School of Law Scholarly Articles McGeorge School of Law Faculty Scholarship 2018 Ethical Cannabis Lawyering in California Francis J. Mootz III University of the Pacific, McGeorge School of Law, [email protected] Follow this and additional works at: https://scholarlycommons.pacific.edu/facultyarticles Part of the Legal Ethics and Professional Responsibility Commons Recommended Citation Mootz, Francis J. III (2018) "Ethical Cannabis Lawyering in California," St. Mary's Journal on Legal Malpractice & Ethics: Vol. 9 : No. 1 , Article 1. This Article is brought to you for free and open access by the McGeorge School of Law Faculty Scholarship at Scholarly Commons. It has been accepted for inclusion in McGeorge School of Law Scholarly Articles by an authorized administrator of Scholarly Commons. For more information, please contact [email protected]. ARTICLE Francis J. Mootz III Ethical Cannabis Lawyering in California Abstract. Cannabis has a long history in the United States. Originally, doctors and pharmacists used cannabis for a variety of purposes. After the Mexican Revolution led to widespread migration from Mexico to the United States, many Americans responded by associating this influx of foreigners with the use of cannabis, and thereby racializing and stigmatizing the drug. After the collapse of prohibition, the federal government repurposed its enormous enforcement bureaucracy to address the perceived problem of cannabis, despite the opposition of the American Medical Association to this new prohibition. Ultimately, both the states and the federal government classified cannabis as a dangerous drug with no therapeutic purpose, treating it the same as cocaine and heroin. Over the past few decades, a number of states have decriminalized cannabis and have permitted residents to purchase cannabis for medical conditions.
    [Show full text]
  • Sample Tokyo Kief CAN+
    170418-001 page 1 of 1 QA Testing PharmLabs San Diego Certificate of Analysis 3421 Hancock St, Second Floor, San Diego, CA 92110 | License: C8-0000098-LIC ISO/IEC 17025:2017 Certification L17-427-1 | Accreditation #85368 Sample Tokyo Kief Sample ID 170418-001 (21576) Matrix Concentrate (Inhalable Cannabis Good) Tested for MANKIND COOP Sampled - Received Apr 18, 2017 Reported May 16, 2017 Analyses executed CAN+ CAN+ - Cannabinoids Analysis Sample photography | Instrument HPLC-VWD | Method SOP-001 Measurement Uncertainty at 95% confidence 7.806% LOD LOQ Result Result Analyte mg/g mg/g % mg/g Cannabidivarin (CBDV) 0.002 0.16 NT NT Cannabidiolic Acid (CBDA) 0.001 0.16 NT NT Cannabigerol Acid (CBGA) 0.001 0.16 NT NT Cannabigerol (CBG) 0.001 0.16 NT NT Cannabidiol (CBD) 0.001 0.16 0.03 0.29 Tetrahydrocannabivarin (THCV) 0.001 0.16 NT NT Cannabinol (CBN) 0.001 0.16 0.34 3.39 Tetrahydrocannabinol (Δ9-THC) 0.003 0.16 17.24 172.38 Δ8-tetrahydrocannabinol (Δ8-THC) 0.004 0.16 NT NT Cannabicyclol (CBL) 0.002 0.006 NT NT Cannabichromene (CBC) 0.002 0.16 NT NT Tetrahydrocannabinolic Acid (THCA) 0.001 0.16 NT NT Total THC (THCa * 0.877 + THC) 17.24 172.38 Total CBD (CBDa * 0.877 + CBD) 0.03 0.29 TOTAL CANNABINOIDS 17.61 176.10 ND Not Detected Authorized Signature N/A Not Applicable NT Not Reported LOD Limit of Detection LOQ Limit of Quantification <LOQ Detected Jaclyn Mauser - Lab Director >ULOL Above upper limit of linearity CFU/g Colony Forming Units per 1 gram Tue, 16 May 2017 14:25:44 -0700 Accreditation #85368 Scan the QR code to TNTC Too Numerous to Count verify authenticity.
    [Show full text]
  • Download the Patient's Guide To
    PATIENT’S GUIDE TO CBD PATIENT'S GUIDE TO CBD AMERICANS FOR SAFE ACCESS 2019 AmericansForSafeAccess.org 1 PATIENT'S GUIDE TO CBD AMERICANS FOR SAFE ACCESS 2019 TABLE OF CONTENTS FOREWORD ...............................................................5 INTRODUCTION ...........................................................8 DEFINITIONS ..............................................................9 CANNABIS SATIVA L.. ......................................................11 AVAILABLE FORMS FOR USE .............................................13 INDICATED USES ..........................................................16 TALKING TO YOUR DOCTOR ABOUT CANNABINOIDS ....................18 FINDING THE RIGHT DOSE. .19 WHAT TO KNOW ABOUT PACKAGING, LABELING, AND HANDLING .....22 THE SUPPLY CHAIN ......................................................30 CHEMICAL STRUCTURE AND ACTIVITY ..................................34 UNDERSTANDING THE ENDOCANNABINOID SYSTEM ...................35 CANNABINOIDS, TERPENES, AND THE ENDOCANNABINOID SYSTEM ...38 FULL-SPECTRUM MEDICINE AND THE ENTOURAGE EFFECT ............38 CERTIFICATIONS AND THE NEED FOR STANDARDS .....................40 CURRENT RESEARCH .....................................................41 CBD ON A GLOBAL SCALE ...............................................42 CONCLUSION ............................................................44 REFERENCES ............................................................45 AMERICANS FOR SAFE ACCESS PATIENT’S GUIDE TO CBD That situation began to change in 1998, however,
    [Show full text]
  • 2018-2019 Coachella Valley Water District Operating Budget
    Fiscal Year Coachella Valley 2018-19 Water District Operating & Capital Improvement Budget COACHELLA VALLEY WATER DISTRICT Operating & Capital Improvement Budget Fiscal Year 2018-19 John P. Powell, Jr., President, Division 3 Cástulo R. Estrada, Vice President, Division 5 G. Patrick O’Dowd, Director, Division 1 Anthony Bianco, Director, Division 2 Peter Nelson, Director, Division 4 Jim Barrett, General Manager Robert Cheng, Assistant General Manager P.O. Box 1058 Coachella, CA 92236 (760) 398-2651 www.cvwd.org The Government Finance Officers Association of the United States and Canada (GFOA) presented a Distinguished Budget Presentation Award to Coachella Valley Water District, California for its annual budget for the fiscal year beginning July 1, 2017. In order to receive this award, a governmental unit must publish a budget document that meets program criteria as a policy document, as an operations guide, as a financial plan, and as a communication device This award is valid for a period of one year only. We believe our current budget continues to conform to the program requirements, as we are submitting it to the GFOA to determine its eligibility for another award. CVWD Mission Statement To meet the water-related needs of the people, through dedicated employees, providing high quality water at a reasonable price. Board of Directors Standing from left: Peter Nelson, Division 4; John P. Powell, Jr., Board President, Division 3; G. Patrick O’Dowd, Division 1. Seated from left: Anthony Bianco, Division 2; Cástulo R. Estrada, Board Vice President, Division 5. Contact Information Acknowledgements This document is produced annually by the Finance and Thomas Rice, Financial Analyst Communications & Conservation departments.
    [Show full text]
  • The Maryland Medical Cannabis Commission's Technical Authority
    THE MARYLAND MEDICAL CANNABIS COMMISSION’S TECHNICAL AUTHORITY FOR MEDICAL CANNABIS TESTING REVISION 3.0 December 15, 2020 The Maryland Medical Cannabis Commission (MMCC) has developed this technical authority document to define contaminants and corresponding action limits associated with those contaminants in medical cannabis. This information is intended for use by the independent testing laboratories registered with the MMCC. Table of Contents Introduction 3 Sampling 4 Collection Procedure for Laboratory Samples 5 Potency 6 Pesticides 7 Residual Solvents 8 Microbiological Impurities 9 Heavy Metals 11 Excipients 13 Stability Testing 13 Appendix A - Medical Cannabis Testing Requirements 14 Appendix B - Definitions 15 Appendix C - Stability Testing Protocol- MMCC Licensed Grower 17 Appendix D - Stability Testing Protocol-MMCC Licensed Processor 19 Appendix E - Stability Testing Protocol-Edibles 21 Appendix F - Microbiological Quality Control 22 Appendix G- Pathogen Detection Storage Requirements 26 References 27 2 MMCC’s TECHNICAL AUTHORITY FOR MEDICAL CANNABIS TESTING 12/15/20 INTRODUCTION Analytical testing of medical cannabis for safety and potency is increasingly recognized as a critical and necessary component of the industry for several reasons (Freeman et al. 2016): ● Laboratory testing minimizes the risk of pesticides, microbes, heavy metals, toxins, and residual solvents from being consumed by an immunocompromised population; ● Quantification of cannabinoid profiles and potency becomes available for the consumer and aids in determining appropriate dosing for individual use; and ● Laboratory testing provides a sense of public safety and product quality for the medical cannabis tested. The Maryland Medical Cannabis Commission (MMCC), with the assistance of a scientific work group, has established this technical authority to serve as a reference guide for the independent testing laboratories (ITL) to follow when analyzing medical cannabis.
    [Show full text]
  • West Coast Leaf
    The Cannabis FREE Newspaper of Record www.WestCoastLeaf.com ISSN 1945-221X • Volume 4 No. 1 Spring 2011 New Directions Big jump in cannabis legislation nationally State lawmakers nationwide Hawaii, Illinois, Rhode Island, Texas, and Virginia) are considering bills to ‘decrimi- weigh marijuana reform nalize’ possession of small amounts of By Morgan Fox, Marijuana Policy Project marijuana, and at least one more state leg- One of the biggest victories for cannabis islature is expected to consider a similar last year was the sheer quantity of publici- proposal during the 2011 legislative ses- ty in the media. After the discussion sur- sion. All the bills would replace possible rounding Props 19 in California, 203 in jail sentences with fines for a modest Arizona, and other major devel opments amount of marijuana (ranging from less around the country, reform is in the lime- than an ounce to up to two ounces). light. More importantly, it is finally being While many argue that marijuana treated as a legitimate policy issue. decrim does not go far enough, it would be This exposure has had an impact in a a tremendous step forward for states like number of state legislatures this session. Texas with Draconian penalties, where More states are considering cannabis more wide-reaching reform is still years Kristin Peskuski addressed a Medical Cannabis Conference held at the senior community reform measures now than ever, and there off. Any step to help keep marijuana users Laguna Woods City Auditorium on Jan. 22. The image behind her depicts super-magnified and is a real possibility that we will see some out of jail deserves support.
    [Show full text]